🇺🇸 FDA
Patent

US 8980952

Methods for treating brain swelling with a compound that blocks a non-selective cation channel

granted A61KA61K31/00A61K31/17

Quick answer

US patent 8980952 (Methods for treating brain swelling with a compound that blocks a non-selective cation channel) held by The United States of America as Represented by the Dept. of Veterans Affairs expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Dept. of Veterans Affairs
Grant date
Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
32
CPC classes
A61K, A61K31/00, A61K31/17, A61K31/175, A61K31/365